Literature DB >> 16252621

Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.

Erna Claes1, Gerry Evers-Kiebooms, Marleen Decruyenaere, Lieve Denayer, Andrea Boogaerts, Kristien Philippe, Eric Legius.   

Abstract

This article describes breast or ovarian cancer surveillance practices and prophylactic surgery involving 34 carriers and 34 noncarriers of a BRCA1/2 mutation within the year after predictive testing. It also evaluates the effect of the predictive test result on cancer screening practices and provides insight into factors important in the decision-making process about health-related behavior. Within the year following predictive testing, 9% (3 of 34) of the carriers decided to have a prophylactic mastectomy. The majority of the carriers was adherent to recommendations regarding regular cancer surveillance following predictive testing. Furthermore, carriers' adherence to clinical breast examination and mammography recommendations significantly increased from pre- to posttest and was significantly higher than noncarriers' utilization after testing. Of the carriers eligible for prophylactic salpingo-oophorectomy, 75% had this operation. All carriers who were advised to have regular surveillance of the ovaries had ovarian ultrasounds. The authors gave major attention to factors playing a part in the decision-making process about health-related behavior.

Entities:  

Mesh:

Year:  2005        PMID: 16252621     DOI: 10.3200/BMED.31.3.93-106

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  16 in total

1.  French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing.

Authors:  C Maheu; T Apostolidis; A Petri-Cal; E Mouret-Fourme; M Gauthier-Villars; C Lasset; P Berthet; J-P Fricker; O Caron; E Luporsi; L Gladieff; C Noguès; C Julian-Reynier
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Development and evaluation of a decision aid for BRCA carriers with breast cancer.

Authors:  Julie O Culver; Deborah J MacDonald; Andrea A Thornton; Sharon R Sand; Marcia Grant; Deborah J Bowen; Harry Burke; Nellie Garcia; Kelly A Metcalfe; Jeffrey N Weitzel
Journal:  J Genet Couns       Date:  2011-03-03       Impact factor: 2.537

3.  Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff; Patricia Rodney
Journal:  Qual Health Res       Date:  2010-10-27

4.  Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.

Authors:  Marc D Schwartz; Claudine Isaacs; Kristi D Graves; Elizabeth Poggi; Beth N Peshkin; Christy Gell; Clinton Finch; Scott Kelly; Kathryn L Taylor; Lauren Perley
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

5.  Self-reported mammography use following BRCA1/2 genetic testing may be overestimated.

Authors:  Geneviève Larouche; Karine Bouchard; Jocelyne Chiquette; Christine Desbiens; Jacques Simard; Michel Dorval
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

6.  Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.

Authors:  E Claes; G Evers-Kiebooms; L Denayer; M Decruyenaere; A Boogaerts; K Philippe; E Legius
Journal:  J Genet Couns       Date:  2005-10       Impact factor: 2.537

7.  Communicating genetic and genomic information: health literacy and numeracy considerations.

Authors:  D H Lea; K A Kaphingst; D Bowen; I Lipkus; D W Hadley
Journal:  Public Health Genomics       Date:  2010-04-20       Impact factor: 2.000

8.  Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.

Authors:  Adam H Buchanan; Corrine I Voils; Joellen M Schildkraut; Catherine Fine; Nora K Horick; P Kelly Marcom; Kristi Wiggins; Celette Sugg Skinner
Journal:  J Genet Couns       Date:  2016-06-06       Impact factor: 2.537

9.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

Review 10.  Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff
Journal:  J Genet Couns       Date:  2009-10-03       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.